Antibiotice (BSE:ATB) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSE:ATB Antibiotice SA BSE:ATB
75 GF Score
Price lei2.14
GF Value lei2.21
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Antibiotice Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BSE:ATB
75GF Score
Antibiotice SA BSE:ATB
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Antibiotice (BSE:ATB) Overvalued in 2026?

Based on GuruFocus' analysis, Antibiotice stock appears to be undervalued. The current stock price of lei2.14 is trading 3.2% below its estimated GF Value™ of lei2.21. GuruFocus considers Antibiotice to be Fairly Valued.

Key valuation signals for BSE:ATB:

  • Short Ratio:
  • GF Value™: lei2.21 vs. price of lei2.14 (3.2% below fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the BSE:ATB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Antibiotice Business Description

Address 1 Valea Lupului Street, Iasi, ROU, 707410
Antibiotice SA is a Romania based company engaged in manufacturing generic medicines. It primarily develops and produces generic medicines for human use, veterinary medicines and active substance Nystatin. The group's generic medicines are primarily targeted at patients with infections, dermatological, cardiovascular, digestive tract diseases or diseases of the musculoskeletal system. It manufactures firm powders for solutions for injection and suspensions for injection (penicillins), capsules, tablets, suppositories and topical preparations (ointments, gels, creams).
75GF Score

Get the complete analysis for BSE:ATB

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei2.14
Price
lei2.21
GF Value